General Description
Synonyms: Acid sodium phosphate; E339; Kalipol 32; monosodium orthophosphate; monosodium phosphate; natrii dihydrogenophosphas dihydricus; phosphoric acid, monosodium salt; primary sodium phosphate; sodium biphosphate; sodium dihydrogen orthophosphate; sodium dihydrogen phosphate.
Description: The USP 32 states that monobasic sodium phosphate contains one or two molecules of water of hydration or is anhydrous. The hydrated forms of monobasic sodium phosphate occur as odorless, colorless or white, slightly deliquescent crystals. The anhydrous form occurs as a white crystalline powder or granules
Chemical Name: Anhydrous monobasic sodium phosphate
Monobasic sodium phosphate monohydrate
Monobasic sodium phosphate dihydrate
Functions
Buffering agent; emulsifying agent; sequestering agent.
Uses
Monobasic sodium phosphate is used in a wide variety of pharmaceutical formulations as a buffering agent and as a sequestering agent.
Therapeutically, monobasic sodium phosphate is used as a mild saline laxative and in the treatment of hypophosphatemia.
Monobasic sodium phosphate is also used in food products, for example, in baking powders, and as a dry acidulant and sequestrant.
Incompatibilities
Monobasic sodium phosphate is an acid salt and is therefore generally incompatible with alkaline materials and carbonates; aqueous solutions of monobasic sodium phosphate are acidic and will cause carbonates to effervesce. Monobasic sodium phosphate should not be administered concomitantly with aluminum, calcium, or magnesium salts since they bind phosphate and could impair its absorption from the gastrointestinal tract. Interaction between calcium and phosphate, leading to the formation of insoluble calcium phosphate precipitates, is possible in parenteral admixtures.
Safety
Monobasic sodium phosphate is widely used as an excipient in parenteral, oral, and topical pharmaceutical formulations. Phosphate occurs extensively in the body and is involved in many physiological processes since it is the principal anion of intracellular fluid. Most foods contain adequate amounts of phosphate, making hypophosphatemia virtually unknown except in certain disease states or in patients receiving total parenteral nutrition. Treatment is usually by the oral administration of up to 100 mmol of phosphate daily.
Handling Precautions
Observe normal precautions appropriate to the circumstances and quantity of material handled. Monobasic sodium phosphate may be irritant to the skin, eyes, and mucous membranes. Eye protection and gloves are recommended.
Related Substances
Dibasic sodium phosphate; monobasic potassium phosphate.